Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  2, 655 - 661 (1996)
doi:10.1038/nm0696-655

Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter

Guy Goudreau1, Stirling Carpenter2, 5, Normand Beaulieu1 & Paul Jolicoeur1, 3, 4, 6

  1Laboratory of Molecular Biology, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec, Canada, H2W 1R7

  2Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, H3A 2B4

  3Department of Microbiology and Immunology, Université de Montréal, Montreal, Quebec, Canada, H3C 3J7

  4Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada, H3G 1A4

  5Present address: Division of Neuropathology, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario, Canada, M5T 2S8

  6Correspondence should be addressed to P.J.

Vacuolar myelopathy is a common neurological complication in AIDS patients. The pathogenesis of this spinal cord white matter disease remains unclear and it is still debated whether infection of spinal cord with the human immunodeficiency virus type 1 (HIV−1) is causing the disease. We have generated transgenic mice expressing the entire HIV−1 genome under the regulation of an oligodendrocyte−specific promoter. These mice develop spinal cord vacuolar lesions similar to those found in AIDS patients. This animal model provides in vivo evidence linking the expression of HIV−1 proteins in oligodendrocytes to the spinal cord damage found in vacuolar myelopathy.

REFERENCES
  1. Goldstick, L., Mandybur, T.I. & Bode, R. Spinal cord degeneration in AIDS. Neurology 35, 103−106 (1985). | PubMed  | ISI | ChemPort |
  2. Petito, C.K. et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 312, 874−879 (1985). | PubMed  | ISI | ChemPort |
  3. Artigas, J., Grosse, G. & Niedobitek, F. Vacuolar myelopathy in AIDS. A morphological study. Pathol. Res. Pract. 186, 228−237 (1990). | PubMed  | ISI | ChemPort |
  4. Bergmann, M., Gullotta, F., Kuchelmeister, K., Masini, T. & Angeli, G. AIDS-myelopathy: A neuropathological study. Pathol. Res. Pract. 189, 58−65 (1993). | PubMed  | ISI | ChemPort |
  5. Eilbott, D.J. et al. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc. Natl. Acad. Sci. USA 86, 3337−3341 (1989). | PubMed  | ChemPort |
  6. Weiser, B. et al. Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. Proc. Natl. Acad. Sci. USA 87, 3997−4001 (1990). | PubMed  | ChemPort |
  7. Tyor, W.R. et al. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43, 1002−1009 (1993). | PubMed  | ISI | ChemPort |
  8. Rosenblum, M. et al. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 39, 892−896 (1989). | PubMed  | ISI | ChemPort |
  9. Grafe, M.R. & Wiley, C.A. Spinal cord and peripheral nerve pathology in AIDS: The roles of cytomegalovirus and human immunodeficiency virus. Ann. Neurol. 25, 561−566 (1989). | PubMed  | ISI | ChemPort |
  10. Hénin, D., Smith, T.W., De Girolami, U., Sughayer, M. & Hauw, J.-J. Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. Hum. Pathol. 23, 1106−1114 (1992). | Article | PubMed  | ISI |
  11. Petito, C.K., Vecchio, D. & Chen, Y.T. HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. J. Neuropathol. Exp. Neurol. 53, 86−94 (1994). | PubMed  | ISI | ChemPort |
  12. Kamin, S. & Petito, C.K. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients. Hum. Pathol. 22, 816−824 (1991). | Article | PubMed  | ISI | ChemPort |
  13. Koenig, S. et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089−1093 (1986). | PubMed  | ISI | ChemPort |
  14. Wiley, C.A., Schrier, R.D., Nelson, J.A., Lampert, P.W. & Oldstone, M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 7089−7093 (1986). | PubMed  | ChemPort |
  15. Vazeux, R. et al. AIDS subacute encephalitis: Identification of HIV-infected cells. Am. J. Pathol. 126, 403−410 (1987). | PubMed  | ISI | ChemPort |
  16. Budka, H. & Lassmann, H. Human immunodeficiency virus in glial cells? J. Infect. Dis. 157, 203 (1988). | PubMed  | ISI |
  17. Sharer, L. & Prineas, J.W. Human immunodeficiency virus in glial cells [continued]? J. Infect. Dis. 157, 204 (1988). | ISI |
  18. Gosztonyi, G., Artigas, J., Lamperth, L. & Webster, H.D. Human immunodeficiency virus (HIV) distribution in HIV encephalitis: Study of 19 cases with combined use of in situ hybridization and immunocytochemistry. J. Neuropathol. Exp. Neural. 53, 521−534 (1994). | ChemPort |
  19. Nuovo, G.J., Gallery, F., MacConnell, P. & Braun, A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144, 659−666 (1994). | PubMed  | ISI | ChemPort |
  20. Korber, B.T. et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68, 7467−7481 (1994). | PubMed  | ISI | ChemPort |
  21. Gyorkey, F., Melnick, J.L. & Gyorkey, P. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J. Infect. Dis. 155, 870−876 (1987). | PubMed  | ISI | ChemPort |
  22. Staler, M.H., Eskin, T.A., Benn, S., Angerer, R.C. & Angerer, L.M. Human T-cell lymphotropic virus type HI infection of the central nervous system. A preliminary in situ study. JAMA 256, 2360−2364 (1986). | PubMed  |
  23. Pumarola-Sune, T., Navia, B.A., Cordon-Cardo, C., Cho, E.S. & Price, R.W. HIV antigen in the brains of patients with the AIDS dementia complex. Ann. Neural. 21, 490−496 (1987). | ChemPort |
  24. Esiri, M., Morris, C.S. & Miliard, P.R. Fate of oligodendrocytes in HIV-1 infection. AIDS 5, 1081−1088 (1991). | PubMed  | ISI | ChemPort |
  25. Bagasra, O. et al. Cellular reservoirs of HIV-1 in the central nervous system of infected-individuals: Identification by the combination of in situ PCR and immunohistochemistry. AIDS (in the press).
  26. Embretson, J. et al. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc. Natl. Acad. Sci. USA 90, 357−361 (1993). | PubMed  | ChemPort |
  27. Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284−291 (1986). | PubMed  | ISI | ChemPort |
  28. Katsuki, M. et al. Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice. Science 241, 593−595 (1988). | PubMed  | ISI | ChemPort |
  29. Allinquant, B., Staugaitis, S.M., D'Urso, D. & Colman, D.R. The ectopic expression of myelin basic protein isoforms in shiverer oligodendrocytes: Implications for myelinogenesis. J. Cell Biol. 113, 393−403 (1991). | Article | PubMed  | ISI | ChemPort |
  30. Yoshioka, T., Feigenbaum, L. & Jay, G. Transgenic mouse model for central nervous system demyelination. Mol. Cell. Biol. 11, 5479−5486 (1991). | PubMed  | ISI | ChemPort |
  31. Turnley, A.M. et al. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 353, 566−569 (1991). | Article | PubMed  | ISI | ChemPort |
  32. Allan, J.S. et al. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810−813 (1985). | PubMed  | ISI | ChemPort |
  33. Arya, S.K. & Gallo, R.C. Three novel genes of human T-lymphotropic virus type III: Immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 2209−2213 (1986). | PubMed  | ChemPort |
  34. Toggas, S.M. et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188−193 (1994). | Article | PubMed  | ISI | ChemPort |
  35. Saito, Y. et al. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44, 474−481 (1994). | PubMed  | ISI | ChemPort |
  36. Tornatore, C., Chandra, R., Berger, J.R. & Major, E.O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44, 481−487 (1994). | PubMed  | ISI | ChemPort |
  37. Ranki, A. et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 5, 1001−1008 (1995).
  38. Green, R., van Tonder, S.V., Oettle, G.J., Cole, G. & Metz, J. Neurological changes in fruit bats deficient in vitamin B12. Nature 254, 148−150 (1975). | PubMed  | ISI | ChemPort |
  39. Scalabrino, G. et al. Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Lab. Invest. 72, 114−123 (1995). | PubMed  | ISI | ChemPort |
  40. Takahashi, N., Roach, A., Teplow, D.B., Prusiner, S.B. & Hood, L. Cloning and characterization of the myelin basic protein gene from mouse: One gene can encode both 14 kD and 18.5 kD MBPs by alternate use of exons. Cell 42, 139−148 (1985). | Article | PubMed  | ISI | ChemPort |
  41. Bouchard, L., Lamarre, L., Tremblay, P.J. & Jolicoeur, P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57, 931−936 (1989). | Article | PubMed  | ISI | ChemPort |
  42. Sambrook, J., Frisch, E.F. & Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
  43. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156−159 (1987). | Article | PubMed  | ISI | ChemPort |
  44. McLean, I.W. & Nakane, P.K. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22, 1077−1083 (1974). | PubMed  | ISI | ChemPort |
  45. Gravel, C., Kay, D.G. & Jolicoeur, P. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J. Virol. 67, 6648−6658 (1993). | PubMed  | ISI | ChemPort |
  46. Jolicoeur, P., Laperrière, A. & Beaulieu, N. Efficient production of human immunodeficiency virus proteins in transgenic mice. J. Virol. 66, 3904−3908 (1992). | PubMed  | ISI | ChemPort |
  47. Thomas, F.P., Chalk, C., Lalonde, R., Robitaille, Y. & Jolicoeur, P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J. Virol. 68, 7099−7107 (1994). | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy